With the advancement of infrastructure, Chinese Healthcare Industry is entering into a new era of development. A large population-base along with increasing aging population, and continuously growing prevalence of lifestyle diseases are further supporting the advancement of the industry. Moreover, increased government spending, worth US$ 120 Billion in 2010 has also facilitated the development of healthcare infrastructure. On the back of all these factors, it is projected that Chinese healthcare sector will surpass all the other sectors in the nation in terms of growth.
Further, according to our new research report, “China Healthcare Market Forecast to 2015”, the promising China healthcare sector is forecast to develop its expenditure growth at a CAGR of around 19% during 2012-2015. Our report entails detailed analysis and forecast of China healthcare sector covering major segments, such as Beds in Health Institutions and Health Professionals in Hospitals. It also enumerates extensive information on Chinese hospital services market with a detailed statistics on infrastructure, Hospitals, Grass-roots Health Care Institution, and Specialized Public Health Institution. Apart from it, our report also provides state-level analysis on Health Institutions, Infrastructure, and inpatients & outpatients.
During our analysis, we also found that Healthcare-IT sector is rapidly gaining momentum in China’s Healthcare sector, drawing huge investments from the government sector. Our report has also focused information on the booming m-health and e-health markets along with the opportunities provided by these markets in the country.
Besides, our report also provides glimpses of the country’s demographics, Epidemiological Backdrop, and Health insurance, pertinent to facilitate consultants, industry analysts, and vendors with an in-depth knowledge about the industry and its performance. The report also elucidates all the vital information to facilitate clients in devising an appropriate marketing strategy and assess opportunity areas in China’s healthcare market.
